Advaxis, Inc. (ADXS) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 585 transactions totaling $31.0M, demonstrating a bullish sentiment with $9.0M in net insider flow. The most recent transaction on Feb 7, 2024 involved a transaction of 1,295,813 shares valued at $518.3K.
No significant insider buying has been recorded for ADXS in the recent period.
No significant insider selling has been recorded for ADXS in the recent period.
Based on recent SEC filings, insider sentiment for ADXS is bullish with an Insider Alignment Score of 64/100 and a net flow of $9.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Advaxis, Inc. (ADXS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading ADXS stock, having executed 585 transactions in the past 90 days. The most active insider is Phillip Gross (Executive), who has made 12 transactions totaling $18.9M.
Get notified when executives and directors at ADXS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 7, 2024 | Fund Gp Partners, L.p. Israel Biotech | Executive | Option Exercise | 1,295,813 | $0.40 | $518.3K | Large |
| Feb 7, 2024 | Fund Gp Partners, L.p. Israel Biotech | Executive | Option Exercise | 8,062,500 | $0.40 | $3.2M | Large |
| Feb 7, 2024 | Fund Gp Partners, L.p. Israel Biotech | Executive | Payment | 2,707,581 | $1.25 | $3.4M | Large |
| Feb 7, 2024 | Fund Gp Partners, L.p. Israel Biotech | Executive | Option Exercise | 8,437,500 | $0.40 | $3.4M | Large |
| Feb 7, 2024 | Fund Gp Partners, L.p. Israel Biotech | Executive | Payment | 2,586,905 | $1.25 | $3.2M | Large |
| Feb 7, 2024 | Fund Gp Partners, L.p. Israel Biotech | Executive | Option Exercise | 3,887,438 | $0.40 | $1.6M | Large |
| Feb 7, 2024 | Fund Gp Partners, L.p. Israel Biotech | Executive | Option Exercise | 4,237,687 | $0.40 | $1.7M | Large |
| Feb 7, 2024 | Fund Gp Partners, L.p. Israel Biotech | Executive | Option Exercise | 1,926,221 | $0.40 | $770.5K | Large |
| Oct 18, 2023 | Fund Limited Partnership Amoon Growth | Executive | Other | 0 | $N/A | $0 | |
| Oct 18, 2023 | Fund Gp Partners Ii, L.p. Israel Biotech | Executive | Purchase | 658,858 | $N/A | $0 | |
| Oct 18, 2023 | Fund Gp Partners Ii, L.p. Israel Biotech | Executive | Purchase | 658,858 | $N/A | $0 | |
| Jan 19, 2023 | Sidransky David | Executive | Award | 46 | $N/A | $0 | |
| Mar 13, 2020 | Appel Roni | Executive | Sale | 2,401 | $0.55 | $1.3K | |
| Mar 12, 2020 | Appel Roni | Executive | Sale | 200 | $0.58 | $116 | |
| Mar 11, 2020 | Appel Roni | Executive | Sale | 399 | $0.67 | $267 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 30 | $20.0M | 38.4% |
Exercise(M) | 7 | $11.3M | 21.7% |
Sale(S) | 51 | $11.0M | 21.2% |
Payment(F) | 183 | $7.8M | 15.0% |
Award(A) | 304 | $1.3M | 2.4% |
Conversion(C) | 4 | $367.2K | 0.7% |
Other(J) | 5 | $200.0K | 0.4% |
Discretionary(I) | 1 | $67.6K | 0.1% |
Insiders at Advaxis, Inc. are accumulating shares at an accelerated pace. With 27 insiders making 585 transactions totaling $20.0M in purchases versus $11.0M in sales, the net buying activity of $9.0M signals strong executive confidence. Phillip Gross (Executive) leads the buying activity with $18.9M in transactions across all time.